Companies: 10,795·Total market cap: $144.5T
Erasca, Inc.

Erasca, Inc.

ERASNASDAQHealthcare● Active
$12.87
+$0.90(+7.52%)
Market Cap$4.0B
P/E Ratio
52W High$24.28
52W Low$1.21

Erasca, Inc. (ERAS) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

eras · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 11 Wall Street analysts in the past 3 months

SellBuy

Buy

11 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
9
Hold
2
Sell
0
Strong Sell
0
Total: 11 · Buy rate: 81.8%

12-Month Price Target

High

$30.00

Consensus

$17.50

+36.1% upside

Low

$10.00

Median: $14 · Last Close: $12.86

The Erasca, Inc. (ERAS) analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month ERAS price target is $17.50, representing +36.1% upside from the current price of $12.86.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $18 (36.1%)

Consensus Target

$17.50

36.1% upside

High Target

$30

133.3%

Low Target

$10

-22.2%

Current Price

$12.86

as of today

Based on analyst price targets, the ERAS stock price prediction for the next 12 months ranges from $10 to $30. The consensus ERAS price forecast of $17.50 implies 36.1% upside from the current price of $12.86.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$13.505.00%

1-day model range: $13.36–$13.65. Peak: $13.65 (+5.00%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

36%57%7%
5Buy
8Neutral
1Sell
RSI (14)66.7Neutral
MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · ERAS · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$12.95SELL
MA 10$12.76BUY
MA 20$11.70BUY
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $ERAS · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$12.78BUY
EMA 10$12.56BUY
EMA 20$11.91BUY
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $ERAS · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
B of A Securities2026-06-04
Upgrade ↑
UnderperformNeutral
Mizuho2026-05-12
Maintains
OutperformOutperform
Stifel2026-04-27
Maintains
BuyBuy
JP Morgan2026-03-18
Maintains
OverweightOverweight
Guggenheim2026-03-16
Maintains
BuyBuy
Mizuho2026-03-13
Maintains
OutperformOutperform
Piper Sandler2026-03-13
Maintains
OverweightOverweight
HC Wainwright & Co.2026-03-13
Maintains
BuyBuy
Clear Street2026-03-06
Maintains
BuyBuy
HC Wainwright & Co.2026-01-26
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Erasca, Inc. (ERAS) stock. Of the recent 44 rating actions, 3 were upgrades and 3 were downgrades. 11 analysts currently cover ERAS.

Analyst Recommendation Trends

Buy ratings101
Hold ratings01↑ +1
Sell ratings00

ERAS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$8M

↑ 105.0% YoY

Revenue Next Year

$0M

↓ 95.0% YoY

EPS This Year

$-0.96

EPS Next Year

$-0.56

↓ 41.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ERAS EPS of $-0.96 for the current fiscal year, based on estimates from 8 analysts. The ERAS revenue forecast is $8M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ERAS stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ERAS price target is $17.50 (+36.1% upside), with an analyst consensus of Buy.

The ERAS short-term stock prediction for tomorrow is $13.50 (+5.00%).

Erasca, Inc. trades on NASDAQ under the ticker ERAS. The ERAS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 82% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ERAS forecast · 8 questions

According to 11 Wall Street analysts, the average 12-month ERAS price target is $17.50, with a high forecast of $30.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies +36.1% potential upside from the current price of $12.86.

ERAS price targetWhat is ERAS price targetERAS analyst price targetERAS 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.